Hints and tips:
...SoftBank’s latest disruptive technology play: a Swiss pharmaceutical company founded in the 19th century....
...Among the more recent targets was GW Pharmaceuticals, a British pioneer in cannabis-based medicines that was acquired by US group Jazz Pharmaceuticals for $7.2bn....
...Support services (19% EBITA) saw EBITA increase to £47m from £46m (despite restructuring and regulatory cycles) as the division focused on a smaller portfolio....
...Any interventions "must be intended to secure, and be consistent with, the welfare of the future person, and they should not increase disadvantage, discrimination or division in society”....
...He sold divisions including plastic, domestic appliances, entertainment and — most radically — financial services, returning more than $130bn to shareholders in dividends....
...In April the drugmaker agreed a three-way asset swap with Novartis through which GSK loses its oncology arm and bulks up its consumer and vaccines divisions....
...In the pharmaceuticals sector, the French government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow up Aventis....
...In Europe, pharmaceuticals underperformed the wider market as investors shunned defensive stocks. Switzerland’s Novartis edged up 0.3 per cent to SFr59.20, erasing early losses....
...German steel group Salzgitter closed 9.8 per cent up €129.94 after revealing that the TCI private equity fund had built up a 3.03 per cent voting stake....
...: Leading a Great Enterprise through Dramatic Change, by Louis V Gerstner ………………………………………………………………………………………………………………………….....
...K.V....
...planning software, Airbus in aircraft manufacture, Novartis in pharmaceuticals, BP in oil and HSBC in banking....
...After graduation, he jumped straight into America’s heartland, taking a job in Nebraska with Sandoz, a drugmaker now owned by Novartis....
International Edition